on February 11, 2008
Published online before print February 11, 2008, doi: 10.1161/CIRCULATIONAHA.107.743963
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 3, 2007
From Emory University School of Medicine, Atlanta, Ga (L.J.S., E.V.); Cedars-Sinai Medical Center, Los Angeles, Calif (D.S.B., S.W.H., J.F., P.S., G. Germano); Vanderbilt University Medical Center, Nashville, Tenn (D.J.M.); Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada (G.B.J.M.); Veterans Affairs Cooperative Studies Program Coordinating Center, Veterans Affairs Connecticut Healthcare System, West Haven (P.M.H.); Christiana Care Health System, Newark, Del (W.S.W.); South Texas Veterans Health Care System, San Antonio, Tex (R.A.O., G.V.H.); Hartford Hospital, Hartford, Conn (M.D.); Mid America Heart Institute/University of Missouri–Kansas City, Kansas City, Mo (J.A.S., B.M.); St Louis University, St Louis, Mo (B.R.C.); Montreal Heart Institute, Montreal, Quebec, Canada (G. Gosselin); Geisinger Clinic, Danville, Pa (P.B.); London Health Sciences Centre, London, Ontario, Canada (W.J.K.); University of Rochester, Rochester, NY (R.G.S.); Foothills Hospital, Calgary, Alberta, Canada (M.K.); University of Michigan, Ann Arbor (E.R.B.); McMaster University, Hamilton, Ontario, Canada (K.K.T.); and Western New York Veterans Affairs Healthcare Network/Buffalo General Hospital/State University of New York, Buffalo (W.E.B.). * To whom correspondence should be addressed. E-mail: leslee.shaw{at}emory.edu.
Background—Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the effectiveness of percutaneous coronary intervention (PCI) for ischemia reduction added to optimal medical therapy (OMT) with the use of myocardial perfusion single photon emission computed tomography (MPS). Methods and Results—Of the 2287 COURAGE patients, 314 were enrolled in this substudy of serial rest/stress MPS performed before treatment and 6 to 18 months (mean=374±50 days) after randomization using paired exercise (n=84) or vasodilator stress (n=230). A blinded core laboratory analyzed quantitative MPS measures of percent ischemic myocardium. Moderate to severe ischemia encumbered Conclusions—In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone. Our findings suggest a treatment target of
Accepted on January 8, 2008
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden. Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw PhD*,
10% myocardium. The primary end point was 5% reduction in ischemic myocardium at follow-up. Treatment groups had similar baseline characteristics. At follow-up, the reduction in ischemic myocardium was greater with PCI+OMT (-2.7%; 95% confidence interval, -1.7%, -3.8%) than with OMT (-0.5%; 95% confidence interval, -1.6%, 0.6%; P<0.0001). More PCI+OMT patients exhibited significant ischemia reduction (33% versus 19%; P=0.0004), especially patients with moderate to severe pretreatment ischemia (78% versus 52%; P=0.007). Patients with ischemia reduction had lower unadjusted risk for death or myocardial infarction (P=0.037 [risk-adjusted P=0.26]), particularly if baseline ischemia was moderate to severe (P=0.001 [risk-adjusted P=0.08]). Death or myocardial infarction rates ranged from 0% to 39% for patients with no residual ischemia to 10% residual ischemia on follow-up MPS (P=0.002 [risk-adjusted P=0.09]).5% ischemia reduction with OMT with or without coronary revascularization.
Key words: ischemia • perfusion • prevention • prognosis
Related Article:
Circulation 2008 117: 1247.
This article has been cited by other articles:
 |
|
 |
|
  G. Sarno, I. Decraemer, P. K. Vanhoenacker, B. De Bruyne, M. Hamilos, T. Cuisset, E. Wyffels, J. Bartunek, G. R. Heyndrickx, and W. Wijns On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization: A Comparison With Invasive Angiography J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Berman and J. K. Min Can Coronary Computed Tomographic Angiography Trigger Coronary Revascularization?: Questioning the Appropriateness of the Question J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 558 - 560. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Giugliano, J. A. White, C. Bode, P. W. Armstrong, G. Montalescot, B. S. Lewis, A. van `t Hof, L. G. Berdan, K. L. Lee, J. T. Strony, et al. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2176 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography? J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Min and D. Berman Anatomic and Functional Assessment of Coronary Artery Disease: Convergence of 2 Aims in a Single Setting Circ Cardiovasc Imaging, May 1, 2009; 2(3): 163 - 165. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A A Fox COURAGE to change practice? Revascularisation in patients with stable coronary artery disease Heart, May 1, 2009; 95(9): 689 - 692. [Full Text] [PDF]
|
|
|
|
|
|
E. Nagel Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 434 - 436. [Full Text] [PDF]
|
|
|
|
 |
|
 T Chua The evolving role of molecular imaging for coronary artery disease: where do we stand today? Heart Asia, March 6, 2009; 2009(2): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Husmann, B. A. Herzog, O. Gaemperli, F. Tatsugami, N. Burkhard, I. Valenta, P. Veit-Haibach, C. A. Wyss, U. Landmesser, and P. A. Kaufmann Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating Eur. Heart J., March 1, 2009; 30(5): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stirrup, K. Wechalekar, A. Maenhout, and C. Anagnostopoulos Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes Br. Med. Bull., March 1, 2009; 89(1): 63 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Neglia and A. L'Abbate Myocardial Perfusion Reserve in Ischemic Heart Disease J. Nucl. Med., February 1, 2009; 50(2): 175 - 177. [Full Text] [PDF]
|
|
|
|
|
|
P. A.L. Tonino, B. De Bruyne, N. H.J. Pijls, U. Siebert, F. Ikeno, M. van `t Veer, V. Klauss, G. Manoharan, T. Engstrom, K. G. Oldroyd, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention N. Engl. J. Med., January 15, 2009; 360(3): 213 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Ellis Refining the Art and Science of Coronary Stenting N. Engl. J. Med., January 15, 2009; 360(3): 292 - 294. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbons, P. A. Araoz, and E. E. Williamson The year in cardiac imaging. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70. [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Joshi Letter by Joshi Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e838 - e838. [Full Text] [PDF]
|
|
|
|
|
|
G. Tarantini, R. Razzolini, and S. Iliceto Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e839 - e839. [Full Text] [PDF]
|
|
|
|
|
|
L. J. Shaw, E. Veledar, D. S. Berman, S. W. Hayes, J. Friedman, P. Slomka, G. Germano, D. J. Maron, G. B. J. Mancini, P. M. Hartigan, et al. Response to Letters Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" Circulation, December 16, 2008; 118(25): e840 - e841. [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Lin, R. A. Dudley, F. L. Lucas, D. J. Malenka, E. Vittinghoff, and R. F. Redberg Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention JAMA, October 15, 2008; 300(15): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Diamond and S. Kaul The Disconnect Between Practice Guidelines and Clinical Practice--Stressed Out JAMA, October 15, 2008; 300(15): 1817 - 1819. [Full Text] [PDF]
|
|
|
|
 |
|
 Percutaneous Coronary Intervention Reduces Ischemia in COURAGE Substudy Journal Watch Cardiology, April 30, 2008; 2008(430): 3 - 3. [Full Text]
|
|